| 1 |
Xie J，Wang H，Kang Y，et al.The epidemiology of sepsis in Chinese ICUs：a national cross-sectional survey ［J］.Crit Care Med，2020，48（3）：e209-e218.
|
| 2 |
Schmoch T，Mohnle P，Weigand MA，et al.The prevalence of sepsisinduced coagulopathy in patients with sepsis - a secondary analysis of two German multicenter randomized controlled trials ［J］.Ann Intensive Care，2023，13（1）：3.
|
| 3 |
Tanaka C，Tagami T，Kudo S，et al.Validation of sepsis-induced coagulopathy score in critically ill patients with septic shock：post hoc analysis of a nationwide multicenter observational study in Japan ［J］.Int J Hematol，2021，114（2）：164-171.
|
| 4 |
Levi M，Van Der Poll T.Coagulation and sepsis ［J］.Thromb Res，2017，149：38-44.
|
| 5 |
Cecconi M，Evans L，Levy M，et al.Sepsis and septic shock ［J］.Lancet，2018，392（10141）：75-87.
|
| 6 |
Williams B，Zou L，Pittet JF，et al.Sepsis-induced coagulopathy：a comprehensive narrative review of pathophysiology，clinical presentation，diagnosis，and management strategies ［J］.Anesth Analg，2024，138（4）：696-711.
|
| 7 |
Iba T，Helms J，Levy JH.Sepsis-induced coagulopathy （SIC） in the management of sepsis ［J］.Ann Intensive Care，2024，14（1）：148.
|
| 8 |
Maneta E，Aivalioti E，Tual-Chalot S，et al.Endothelial dysfunction and immunothrombosis in sepsis ［J］.Front Immunol，2023，14：1144229.
|
| 9 |
Navarrete S，Solar C，Tapia R，et al.Pathophysiology of deep vein thrombosis ［J］.Clin Exp Med，2023，23（3）：645-654.
|
| 10 |
Portier I，Campbell RA.Role of platelets in detection and regulation of infection ［J］.Arterioscler Thromb Vasc Biol，2021，41（1）：70-78.
|
| 11 |
Guo L，Shen S，Rowley JW，et al.Platelet MHC class Ⅰ mediates CD8+T-cell suppression during sepsis ［J］.Blood，2021，138（5）：401-416.
|
| 12 |
Leung G，Middleton EA.The role of platelets and megakaryocytes in sepsis and ARDS ［J］.J Physiol，2024，602（22）：6047-6063.
|
| 13 |
Rondina MT，Carlisle M，Fraughton T，et al.Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock ［J］.J Gerontol A Biol Sci Med Sci，2015，70（2）：225-231.
|
| 14 |
Su M，Chen C，Li S，et al.Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis ［J］.Nat Cardiovasc Res，2022，1（8）：732-747.
|
| 15 |
Herre M，Cedervall J，Mackman N，et al.Neutrophil extracellular traps in the pathology of cancer and other inflammatory diseases ［J］.Physiol Rev，2023，103（1）：277-312.
|
| 16 |
宋景春，丁仁彧，吕奔，等.脓毒症性凝血病诊疗中国专家共识（2024 版） ［J］.解放军医学杂志，2024，49（11）：1221-1236.
|
| 17 |
Deng M，Tang Y，Li W，et al.The endotoxin delivery protein HMGB1 mediates caspase-11-dependent lethality in sepsis ［J］.Immunity，2018，49（4）：740-753 e7.
|
| 18 |
Vanaja SK，Russo AJ，Behl B，et al.Bacterial outer membrane vesicles mediate cytosolic localization of LPS and Caspase-11 activation ［J］.Cell，2016，165（5）：1106-1119.
|
| 19 |
Yang X，Cheng X，Tang Y，et al.Bacterial endotoxin activates the coagulation cascade through Gasdermin D-dependent phosphatidylserine exposure ［J］.Immunity，2019，51（6）：983-996.e6.
|
| 20 |
Wu C，Lu W，Zhang Y，et al.Inflammasome activation triggers blood clotting and host death through pyroptosis ［J］.Immunity，2019，50（6）：1401-1411.e4.
|
| 21 |
Zhang H，Zeng L，Xie M，et al.TMEM173 drives lethal coagulation in sepsis ［J］.Cell Host Microbe，2020，27（4）：556-570.e6.
|
| 22 |
Singer M，Deutschman CS，Seymour CW，et al.The third international consensus definitions for sepsis and septic shock （Sepsis-3） ［J］.JAMA，2016，315（8）：801-810.
|
| 23 |
Wang H，Ding H，Wang ZY，et al.Research progress on microcirculatory disorders in septic shock：a narrative review ［J］.Medicine （Baltimore），2024，103（8）：e37273.
|
| 24 |
Tobiasch AK，Lehner GF，Feistritzer C，et al.Extracellular vesicle tissue factor and tissue factor pathway inhibitor are independent discriminators of sepsis-induced coagulopathy ［J］.Res Pract Thromb Haemost，2024，8（7）：102596.
|
| 25 |
Ninan KF，Iyadurai R，Varghese JK，et al.Thromboelastograph：a prognostic marker in sepsis with organ dysfunction without overt bleeding ［J］.J Crit Care，2021，65：177-183.
|
| 26 |
Damiani E，Carsetti A，Casarotta E，et al.Microcirculation-guided resuscitation in sepsis：the next frontier? ［J］.Front Med （Lausanne），2023，10：1212321.
|
| 27 |
Zhang J，Xue M，Chen Y，et al.Identification of soluble thrombomodulin and tissue plasminogen activator-inhibitor complex as biomarkers for prognosis and early evaluation of septic shock and sepsis-induced disseminated intravascular coagulation ［J］.Ann Palliat Med，2021，10（10）：10170-10184.
|
| 28 |
Li J，Zhou J，Ren H，et al.Clinical efficacy of soluble thrombomodulin，tissue plasminogen activator inhibitor complex，thrombin-antithrombin complex，alpha2-plasmininhibitor-plasmin complex in pediatric sepsis［J］.Clin Appl Thromb Hemost，2022，28：10760296221102929.
|
| 29 |
Delabranche X，Boisrame-Helms J，Asfar P，et al.Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulopathy ［J］.Intensive Care Med，2013，39（10）：1695-1703.
|
| 30 |
Stiel L，Delabranche X，Galoisy AC，et al.Neutrophil fluorescence：a new indicator of cell activation during septic shock-induced disseminated intravascular coagulation ［J］.Crit Care Med，2016，44（11）：e1132-e1136.
|
| 31 |
Shimizu M，Konishi A，Nomura S.Examination of biomarker expressions in sepsis-related DIC patients ［J］.Int J Gen Med，2018，11：353-361.
|
| 32 |
Stiel L，Mayeur-Rousse C，Helms J，et al.First visualization of circulating neutrophil extracellular traps using cell fluorescence during human septic shock-induced disseminated intravascular coagulation ［J］.Thromb Res，2019，183：153-158.
|
| 33 |
Galliera E，Tacchini L，Corsi Romanelli MM.Matrix metalloproteinases as biomarkers of disease：updates and new insights［J］.Clin Chem Lab Med，2015，53（3）：349-355.
|
| 34 |
Lorente L，Martin MM，Sole-Violan J，et al.Association of sepsisrelated mortality with early increase of TIMP-1/MMP-9 ratio ［J］.PLoS One，2014，9（4）：e94318.
|
| 35 |
Sivula M，Hastbacka J，Kuitunen A，et al.Systemic matrix metalloproteinase-8 and tissue inhibitor of metalloproteinases-1 levels in severe sepsis-associated coagulopathy ［J］.Acta Anaesthesiol Scand，2015，59（2）：176-184.
|
| 36 |
Zhang Y，Wang L，Kuang X，et al.Diagnostic and prognostic value of C1q in sepsis-induced coagulopathy ［J］.Clin Appl Thromb Hemost，2024，30：10760296241257517.
|
| 37 |
Sun Y，Sun H，Feng J，et al.Immunosuppression correlates with the deterioration of sepsis-induced disseminated intravascular coagulation［J］.Shock，2024，61（5）：666-674.
|
| 38 |
Han Y，Duan J，Chen M，et al.Relationship between serum sodium level and sepsis-induced coagulopathy ［J］.Front Med （Lausanne），2023，10：1324369.
|
| 39 |
Kiya GT，Abebe G，Mekonnen Z，et al.A comparison of disseminated intravascular coagulation scoring systems and their performance to predict mortality in sepsis patients：a systematic review and metaanalysis ［J］.PLoS One，2025，20（1）：e0315797.
|
| 40 |
Zhao H，Dong Y，Wang S，et al.Comparison between sepsis-induced coagulopathy and sepsis-associated coagulopathy criteria in identifying sepsis-associated disseminated intravascular coagulation ［J］.World J Emerg Med，2024，15（3）：190-196.
|
| 41 |
Zhou S，Lu Z，Liu Y，et al.Interpretable machine learning model for early prediction of 28-day mortality in ICU patients with sepsisinduced coagulopathy：development and validation ［J］.Eur J Med Res，2024，29（1）：14.
|
| 42 |
Rhodes A，Evans LE，Alhazzani W，et al.Surviving sepsis campaign：international guidelines for management of sepsis and septic shock：2016 ［J］.Crit Care Med，2017，45（3）：486-552.
|
| 43 |
Evans L，Rhodes A，Alhazzani W，et al.Surviving sepsis campaign：international guidelines for management of sepsis and septic shock 2021 ［J］.Intensive Care Med，2021，47（11）：1181-1247.
|
| 44 |
Egi M，Ogura H，Yatabe T，et al.The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 （J-SSCG 2020） ［J］.Acute Med Surg，2021，8（1）：e659.
|
| 45 |
Umemura Y，Yamakawa K，Ogura H，et al.Efficacy and safety of anticoagulant therapy in three specific populations with sepsis：a metaanalysis of randomized controlled trials ［J］.J Thromb Haemost，2016，14（3）：518-530.
|
| 46 |
Ushio N，Yamakawa K，Mochizuki K，et al.Efficacy of unfractionated heparin in patients with moderate sepsis-induced coagulopathy：an observational study ［J］.Thromb Res，2024，241：109095.
|
| 47 |
Wang R，Liu R，Xu Z.Association between plasma transfusion and in-hospital mortality in critically ill patients with sepsis-induced coagulopathy ［J］.Shock，2023，60（4）：545-552.
|
| 48 |
Ishikura H，Nakamura Y，Kawano Y，et al.Intravenous immunoglobulin improves sepsis-induced coagulopathy：a retrospective，single-center observational study ［J］.J Crit Care，2015，30（3）：579-583.
|
| 49 |
Wand S，Klages M，Kirbach C，et al.IgM-enriched immunoglobulin attenuates systemic endotoxin activity in early severe sepsis：a beforeafter cohort study ［J］.PLoS One，2016，11（8）：e0160907.
|
| 50 |
Zou F，Tang X，Lei X，et al.Treatment efficacy of continuous renal replacement on symptoms，inflammatory mediators，and coagulation function in patients with sepsis-associated acute kidney injury ［J］.Arch Esp Urol，2022，75（9）：746-752.
|
| 51 |
Wu S，Xu T，Wu C，et al.Continuous renal replacement therapy in sepsis-associated acute kidney injury：effects on inflammatory mediators and coagulation function ［J］.Asian J Surg，2021，44（10）：1254-1259.
|
| 52 |
Osawa I，Goto T，Kudo D，et al.Targeted therapy using polymyxin B hemadsorption in patients with sepsis：a post-hoc analysis of the JSEPTIC-DIC study and the EUPHRATES trial ［J］.Crit Care，2023，27（1）：245.
|
| 53 |
Aydin K，Korkmaz S，Erkurt MA，et al.Apheresis in patients with sepsis：a multicenter retrospective study ［J］.Transfus Apher Sci，2021，60（5）：103239.
|
| 54 |
Zhang J，Zhu X，Li Y，et al.Parthenolide improves sepsis-induced coagulopathy by inhibiting mitochondrial-mediated apoptosis in vascular endothelial cells through BRD4/BCL-xL pathway ［J］.J Transl Med，2025，23（1）：80.
|
| 55 |
Guo NK，She H，Tan L，et al.Nano Parthenolide improves intestinal barrier function of sepsis by inhibiting apoptosis and ROS via 5-HTR2A ［J］.Int J Nanomedicine，2023，18：693-709.
|
| 56 |
Zhou X，Xin G，Wan C，et al.Myricetin reduces platelet PANoptosis in sepsis to delay disseminated intravascular coagulation ［J］.Biochem Biophys Res Commun，2024，724：150140.
|
| 57 |
Zhang W，Bhandari S，Ding Y，et al.Polyunsaturated fatty acid-derived lipid mediator resolvin D1 alleviates sepsis-induced disseminated intravascular coagulation via Caspase-1/Gasdermin D pyroptotic pathway ［J］.Clin Nutr，2024，43（6）：1372-1383.
|
| 58 |
Liu Z，Li X，Chen M，et al.Heparin-binding protein and sepsisinduced coagulopathy：modulation of coagulation and fibrinolysis via the TGF-beta signalling pathway ［J］.Thromb Res，2024，244：109176.
|
| 59 |
Zhong T，Zhang J，Chen S，et al.Magnesium sulfate ameliorates histone-induced coagulation dysfunction and lung damage in mice ［J］.Shock，2024，61（1）：132-141.
|